GlaxoSmithKline (GSK)

Tweet this page
<
>
How to read and use this data card.
LOADING...
1717450
7733930729fd446cbc0c95ed6160a091

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

1,000,000€ - 1,249,999€

Financial year: 01/01/2020 - 01/12/2020

Lobbyists declared: 5.25 FTE (9)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

5
0.25

Lobbyists with EP accreditation: 4

1
1
1
1

Meetings with European Commission: 11

Lobbying costs over the years:

1
5
10
100
1000

GlaxoSmithKline (GSK)

Registration on EU Transparency Register

7990322925-77 (First registered: 06 Jan 2009)

Goals / Remit

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people. Our operations span the value chain from identifying, researching, developing and testing ground-breaking discoveries, to regulatory approval, manufacturing and commercialisation. We have over 94,000 employees globally across 96 countries, with outstanding scientific and technical know-how and deep expertise. In Europe, we employ over 25,000 people, with 14 manufacturing sites and 4 R&D sites in EU countries.

Issues

We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses. This includes topics such as R&D and clinical trials, the EU Beating Cancer Plan, health technology assessment, antimicrobial resistance, digital health, pharmaceutical legislation, medical devices, vaccines, trade, industrial strategy, IP, environment.

Address

Head office:
Great West Road, 980
Brentford, Middlesex TW8 9GS
United Kingdom

Tel: 44 20 8047 5000

Belgium office:
37 Square de Meeûs
Brussels 1000,
Belgium

Tel: 32 27917600